単一細胞分析市場

出版:MarketsandMarkets

Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, PCR, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) – Global Forecast to 2026
種別英文調査報告書
出版MarketsandMarkets
出版年月2021年 9月
ページ数297
図表数314
レポート目次 お問合せ
単一細胞分析市場 細胞タイプ(ヒト、動物、微生物)、製品(消耗品、機器)、技術(フローサイトメトリー、NGS、PCR、顕微鏡、MS)、用途(研究、医療)、エンドユーザー(製薬、バイオテクノロジー、病院)別The global single-cell analysis market is projected to reach USD 6.3billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1%during the forecast period. Growth in the single-cell analysis market can mainly be attributed to factors such as technological advancements in single-cell analysis products, rising prevalence of cancer, increasing R&D in the pharmaceutical & biotechnology industries for complex diseases, growth in stem cell research, and growing focus on personalized medicine. On the other hand, the high cost of single-cell analysis instruments is expected to hinder market growth to a certain extent. “The consumables segment accounted for the highest growth rate in the single-cell analysismarket, byproduct, during the forecast period”Consumables accounted for the largest share of 67.4% of the single-cell analysis market in 2020. The large share of this segment can primarily be attributed to the frequent purchase of these products compared to instruments, which are considered a one-time investment. The wide applications of consumables in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are also expected to drive market growth.“Human cells segment accounted for the largest share”The single-cell analysis market is segmented into human cells, animal cells, and microbial cells. The human cells segment accounted for the largest share of 51.6% of the single-cell analysis market in 2020. The large share of this segment can be attributed to the high utilization of human cells in research laboratories and academic institutes.“Asia Pacific: The fastest-growing regionin thesingle-cell analysismarket”The market in the Asia Pacific is expected to grow at the highest CAGR of 17.4% during the forecast period. This can be attributed to the fast-growing pharmaceutical industry in this region, rising geriatric population, rising prevalence of cancer, and increasing government initiatives.The primary interviews conducted for this report can be categorized as follows:•By Respondent: Supply Side- 80%and Demand Side 20%•By Designation: C-level – 25%, D-level – 20%, and Others – 55%•By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%Lists of Companies Profiled in the Report:•Becton, Dickinson and Company (US)•Danaher Corporation (US)•Merck KGAA (Germany)•QIAGEN N.V. (Netherlands)•Thermo Fisher Scientific, Inc. (US)•10x Genomics (US)•Promega Corporation (US)•Illumina, Inc. (US)•Bio-Rad Laboratories (US)•Fluidigm Corporation (US)•Agilent Technologies, Inc. (US)•Tecan Group Ltd. (Switzerland)•Sartorius AG (Germany)•Luminex Corporation (US)•Takara Bio (Japan)•Fluxion Biosciences (US)•Menarini Silicon Biosystems, Inc. (Italy)•bioMérieux SA (France)•Oxford Nanopore Technologies (UK)•Cytek Biosciences (US)•Corning Incorporated (US)•Apogee Flow Systems Ltd. (UK)•NanoCellect Biomedical (US)•Rarecyte Inc (US)•On-chip Biotechnologies Co., Ltd. (Japan).Research Coverage:This report provides a detailed picture of thesingle-cell analysis market. It aims at estimating the size and future growth potential of the market across different segments such as theproduct, cell type, technique, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.Key Benefits of Buying the Report:The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-cell analysis marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers,restraints and opportunities.

目次

1INTRODUCTION261.1OBJECTIVES OF THE STUDY261.2MARKET DEFINITION261.2.1INCLUSIONS AND EXCLUSIONS271.2.2MARKETS COVERED28FIGURE 1MARKET SEGMENTATION281.2.3YEARS CONSIDERED FOR THE STUDY291.3CURRENCY291.4LIMITATIONS291.5STAKEHOLDERS291.6SUMMARY OF CHANGES302RESEARCH METHODOLOGY312.1RESEARCH APPROACH31FIGURE 2RESEARCH DESIGN312.1.1SECONDARY DATA322.1.2PRIMARY DATA33FIGURE 3BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET332.2MARKET DATA ESTIMATION & TRIANGULATION34FIGURE 4DATA TRIANGULATION METHODOLOGY342.3MARKET ESTIMATION METHODOLOGY35FIGURE 5MARKET SIZE ESTIMATION (APPROACH 1): SUPPLY-SIDE ANALYSIS35FIGURE 6MARKET SIZE ESTIMATION (APPROACH 2): SUPPLY-SIDE ANALYSIS36FIGURE 7ILLUSTRATION OF REVENUE SHARE ANALYSIS36FIGURE 8SINGLE-CELL ANALYSIS MARKET: FINAL MARKET SIZE (USD BILLION)372.4GROWTH RATE ASSUMPTIONS/GROWTH FORECAST38FIGURE 9GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS38FIGURE 10FINAL CAGR PROJECTIONS (2021−2026)392.5INSIGHTS FROM PRIMARIES39FIGURE 11MARKET VALIDATION FROM PRIMARY EXPERTS392.6RESEARCH ASSUMPTIONS402.7RISK ASSESSMENT40TABLE 1RISK ASSESSMENT403EXECUTIVE SUMMARY41FIGURE 12SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)41FIGURE 13SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION)42FIGURE 14SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)42FIGURE 15SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)43FIGURE 16SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)44FIGURE 17SINGLE-CELL ANALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)454PREMIUM INSIGHTS464.1SINGLE-CELL ANALYSIS MARKET OVERVIEW46FIGURE 18TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO SUPPORT MARKET GROWTH464.2NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SHARE, BY PRODUCT & COUNTRY (2020)47FIGURE 19CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2020474.3SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)47FIGURE 20CONSUMABLES WILL CONTINUE TO DOMINATE THE SINGLE-CELL ANALYSIS MARKET IN 2026474.4SINGLE-CELL ANALYSIS MARKET SHARE, BY END USER, 202048FIGURE 21ACADEMIC & RESEARCH LABORATORIES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020484.5SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES48FIGURE 22ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE SINGLE-CELL ANALYSIS MARKET FROM 2021 TO 2026485MARKET OVERVIEW495.1INTRODUCTION495.2MARKET DYNAMICS49FIGURE 23SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES49TABLE 2SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS505.2.1DRIVERS505.2.1.1Technological advancements in single-cell analysis products50TABLE 3RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES505.2.1.2Rising prevalence of cancer51TABLE 4PROJECTED INCREASE IN THE NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035525.2.1.3Increasing R&D in the pharmaceutical & biotechnology industries for complex diseases53FIGURE 24INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026535.2.1.4Growth in stem cell research535.2.1.5Growing focus on personalized medicine545.2.2RESTRAINTS555.2.2.1High cost of single-cell analysis products55 5.2.3OPPORTUNITIES555.2.3.1High growth potential of single-cell sequencing555.2.3.2Integration of microfluidics in single-cell analysis565.2.3.3Emerging Asian markets565.3RANGES/SCENARIO57FIGURE 25SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE SINGLE-CELL ANALYSIS MARKET575.4IMPACT OF COVID-19 ON THE SINGLE-CELL ANALYSIS MARKET57FIGURE 26SINGLE-CELL ANALYSIS MARKET SCENARIO: PRE- AND POST-COVID-19 IMPACT, 2019–2021585.5TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES59FIGURE 27REVENUE SHIFT & NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS595.6PRICING ANALYSIS60TABLE 5PRICE OF SINGLE-CELL ANALYSIS PRODUCTS (2020)60TABLE 6AVERAGE SELLING PRICE OF NGS SYSTEMS (2020)605.7VALUE CHAIN ANALYSIS60FIGURE 28MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES615.8SUPPLY CHAIN ANALYSIS62FIGURE 29SUPPLY CHAIN ANALYSIS OF THE SINGLE-CELL ANALYSIS MARKET625.9ECOSYSTEM ANALYSIS63FIGURE 30ECOSYSTEM ANALYSIS: SINGLE-CELL ANALYSIS MARKET63TABLE 7SUPPLY CHAIN ECOSYSTEM635.10TECHNOLOGY ANALYSIS64TABLE 8COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES645.11PATENT ANALYSIS65FIGURE 31PATENTS GRANTED IN THE SINGLE-CELL ANALYSIS MARKET IN THE LAST 10 YEARS65TABLE 9INDICATIVE LIST OF PATENTS IN THE SINGLE-CELL ANALYSIS MARKET665.12REGULATORY ANALYSIS67TABLE 10REGULATORY SCENARIO675.13PORTER’S FIVE FORCES ANALYSIS69TABLE 11SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS695.13.1THREAT FROM NEW ENTRANTS695.13.2THREAT FROM SUBSTITUTES705.13.3BARGAINING POWER OF BUYERS705.13.4BARGAINING POWER OF SUPPLIERS705.13.5COMPETITIVE RIVALRY AMONG EXISTING PLAYERS70 6SINGLE-CELL ANALYSIS MARKET, BY PRODUCT716.1INTRODUCTION72TABLE 12SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)726.2CONSUMABLES72TABLE 13SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)736.2.1BEADS736.2.1.1Wide application of beads in the isolation of RNA and DNA to drive market growth73TABLE 14SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2019–2026 (USD MILLION)746.2.2MICROPLATES746.2.2.1Increasing demand for genomic technologies will boost the market for microplates in the coming years74TABLE 15SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2019–2026 (USD MILLION)756.2.3REAGENTS756.2.3.1Advancements in single-cell genomics are likely to increase the adoption of reagents75TABLE 16SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)766.2.4ASSAY KITS76TABLE 17SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)77TABLE 18SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2019–2026 (USD MILLION)776.2.4.1Immunoassays786.2.4.1.1Innovations in immunoassays to drive the growth of this segment78TABLE 19SINGLE-CELL ANALYSIS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2019–2026 (USD MILLION)786.2.4.2Cell-based assays796.2.4.2.1Rising R&D activities in pharma and biopharma companies will drive the demand for cell-based assays79TABLE 20SINGLE-CELL ANALYSIS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2019–2026 (USD MILLION)796.2.5OTHER CONSUMABLES80TABLE 21SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)806.3INSTRUMENTS80TABLE 22SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)81TABLE 23SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)816.3.1FLOW CYTOMETERS826.3.1.1Technological advancements in flow cytometry to drive the growth of this segment82TABLE 24SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2019–2026 (USD MILLION)836.3.2NGS SYSTEMS836.3.2.1Advancements in NGS systems to support the market growth83TABLE 25SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)846.3.3PCR INSTRUMENTS846.3.3.1Usage of PCR to amplify DNA and mRNA from single cells to study gene expression is expected to boost the market84TABLE 26SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)856.3.4SPECTROPHOTOMETERS856.3.4.1Spectrophotometers play an integral role in the life science industry85TABLE 27SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2019–2026 (USD MILLION)866.3.5MICROSCOPES876.3.5.1Wide applications in cell-based research to drive the adoption of microscopes87TABLE 28SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2019–2026 (USD MILLION)876.3.6CELL COUNTERS886.3.6.1Reliable and quick results associated with cell counters are supporting the growth of this market segment88TABLE 29SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2019–2026 (USD MILLION)886.3.7HCS SYSTEMS896.3.7.1Increasing need for multi-parametric cell analysis to drive the adoption of HCS systems89TABLE 30SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)896.3.8MICROARRAYS906.3.8.1Increasing demand for microarrays in the field of molecular biology to support market growth90TABLE 31SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2019–2026 (USD MILLION)916.3.9OTHER INSTRUMENTS91TABLE 32SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)927SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE937.1INTRODUCTION94TABLE 33SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)947.2HUMAN CELLS947.2.1INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET GROWTH94TABLE 34SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2019–2026 (USD MILLION)95 7.3ANIMAL CELLS967.3.1INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET GROWTH96TABLE 35SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2019–2026 (USD MILLION)967.4MICROBIAL CELLS977.4.1RISING GOVERNMENT SUPPORT TO DETECT & COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET GROWTH97TABLE 36SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2019–2026 (USD MILLION)988SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE998.1INTRODUCTION100TABLE 37SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)1008.2FLOW CYTOMETRY1008.2.1WIDE USAGE OF FLOW CYTOMETRY TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET GROWTH100TABLE 38SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2019–2026 (USD MILLION)1018.3NEXT-GENERATION SEQUENCING1018.3.1NGS IS THE FASTEST-GROWING SEGMENT IN THE SINGLE-CELL ANALYSIS MARKET101TABLE 39SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2019–2026 (USD MILLION)1028.4POLYMERASE CHAIN REACTION1028.4.1LATEST ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH102TABLE 40SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2019–2026 (USD MILLION)1038.5MICROSCOPY1048.5.1INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET GROWTH104TABLE 41SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2019–2026 (USD MILLION)1048.6MASS SPECTROMETRY1058.6.1LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH105TABLE 42SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2019–2026 (USD MILLION)1058.7OTHER TECHNIQUES106TABLE 43SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2019–2026 (USD MILLION)1079SINGLE-CELL ANALYSIS MARKET, BY APPLICATION1089.1INTRODUCTION109TABLE 44SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)109 9.2RESEARCH APPLICATIONS109FIGURE 32INCREASING NUMBER OF CLINICAL TRIALS REGISTERED WORLDWIDE (2000–2021)109TABLE 45SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)110TABLE 46SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)1119.2.1CANCER RESEARCH1119.2.1.1Growing prevalence of cancer to support market growth111TABLE 47SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2019–2026 (USD MILLION)1129.2.2IMMUNOLOGY RESEARCH1129.2.2.1High incidence of infectious diseases and growing demand for advanced vaccines to propel market growth112TABLE 48SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2019–2026 (USD MILLION)1139.2.3NEUROLOGY RESEARCH1149.2.3.1Increasing incidence of neurological disorders to boost the market growth114TABLE 49SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2019–2026 (USD MILLION)1159.2.4STEM CELL RESEARCH1159.2.4.1Rising investments in stem cell research to drive the growth of this application segment115TABLE 50SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2019–2026 (USD MILLION)1169.2.5OTHER RESEARCH APPLICATIONS117TABLE 51SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)1179.3MEDICAL APPLICATIONS118TABLE 52SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)1189.3.1NON-INVASIVE PRENATAL DIAGNOSIS1199.3.1.1Rising prevalence of genetic diseases to drive market growth119TABLE 53SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION)1199.3.2IN VITRO FERTILIZATION1209.3.2.1Increasing demand for in vitro fertilization procedures to support the growth of this application segment120TABLE 54SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2019–2026 (USD MILLION)1209.3.3CIRCULATING TUMOR CELL DETECTION1219.3.3.1Rising prevalence of cancer to contribute to the growth of this segment121TABLE 55SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2019–2026 (USD MILLION)12110SINGLE-CELL ANALYSIS MARKET, BY END USER12210.1INTRODUCTION123TABLE 56SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)12310.2ACADEMIC & RESEARCH LABORATORIES12310.2.1INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE GROWTH IN THIS END-USER SEGMENT123TABLE 57SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)12410.3BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES12510.3.1GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH125TABLE 58SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)12610.4HOSPITALS & DIAGNOSTIC LABORATORIES12610.4.1HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE THE ADOPTION OF SINGLE-CELL ANALYSIS PRODUCTS AMONG HOSPITALS & DIAGNOSTIC LABS126TABLE 59SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)12710.5CELL BANKS & IVF CENTERS12810.5.1RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH128TABLE 60SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)12911SINGLE-CELL ANALYSIS MARKET, BY REGION13011.1INTRODUCTION131TABLE 61SINGLE-CELL ANALYSIS MARKET, BY REGION, 2019–2026 (USD MILLION)13111.2NORTH AMERICA132FIGURE 33NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT132TABLE 62NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)133TABLE 63NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)133TABLE 64NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)133TABLE 65NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)134TABLE 66NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)134TABLE 67NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)135TABLE 68NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)135TABLE 69NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)135TABLE 70NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)136TABLE 71NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)136TABLE 72NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)13611.2.1US13711.2.1.1Increasing R&D investments and funding to drive market growth in the US137FIGURE 34NIH FUNDING IN THE LAST 10 YEARS (2011–2021)137TABLE 73US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)138TABLE 74US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)138TABLE 75US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)138TABLE 76US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)139TABLE 77US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)139TABLE 78US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)140TABLE 79US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)140TABLE 80US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)140TABLE 81US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)141TABLE 82US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)14111.2.2CANADA14111.2.2.1High prevalence of hemophilia to drive market growth in Canada141TABLE 83CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)142TABLE 84CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)142TABLE 85CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)143TABLE 86CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)143TABLE 87CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)143TABLE 88CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)144TABLE 89CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)144TABLE 90CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)144TABLE 91CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)145TABLE 92CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)14511.3EUROPE145TABLE 93EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)146TABLE 94EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)146TABLE 95EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)146TABLE 96EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)147TABLE 97EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)147TABLE 98EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)147TABLE 99EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)148TABLE 100EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)148TABLE 101EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)148TABLE 102EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)149TABLE 103EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)14911.3.1GERMANY14911.3.1.1Government support for research funding to support the growth of the single-cell analysis market in the country149TABLE 104GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)150TABLE 105GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)150TABLE 106GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)150TABLE 107GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)151TABLE 108GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)151TABLE 109GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)152TABLE 110GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)152TABLE 111GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)152TABLE 112GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)153TABLE 113GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)15311.3.2UK15311.3.2.1Growing adoption of single-cell analysis products, coupled with favorable research conditions, to drive market growth in the UK153TABLE 114UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)154TABLE 115UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)154TABLE 116UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)154TABLE 117UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)155TABLE 118UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)155TABLE 119UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)156TABLE 120UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)156TABLE 121UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)156TABLE 122UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)157TABLE 123UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)15711.3.3FRANCE15711.3.3.1Growing government initiatives to boost R&D in the country to propel the adoption of single-cell analysis products157TABLE 124FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)158TABLE 125FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)158TABLE 126FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)158TABLE 127FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)159TABLE 128FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)159TABLE 129FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)160TABLE 130FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)160TABLE 131FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)160TABLE 132FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)161TABLE 133FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)161 11.3.4ITALY16111.3.4.1Advancements in biotechnology and increasing R&D investments by pharmaceutical companies to drive the market for single-cell analysis in Italy161TABLE 134ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)162TABLE 135ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)162TABLE 136ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)162TABLE 137ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)163TABLE 138ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)163TABLE 139ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)164TABLE 140ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)164TABLE 141ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)164TABLE 142ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)165TABLE 143ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)16511.3.5SPAIN16511.3.5.1Strong R&D infrastructure and growing focus on cancer research to support market growth in Spain165TABLE 144SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)166TABLE 145SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)166TABLE 146SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)166TABLE 147SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)167TABLE 148SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)167TABLE 149SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)168TABLE 150SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)168TABLE 151SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)168TABLE 152SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)169TABLE 153SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)16911.3.6REST OF EUROPE169TABLE 154ROE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)170TABLE 155ROE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)170TABLE 156ROE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)171TABLE 157ROE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)171TABLE 158ROE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)171TABLE 159ROE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)172TABLE 160ROE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)172TABLE 161ROE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)172TABLE 162ROE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)173TABLE 163ROE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)17311.4ASIA PACIFIC174FIGURE 35ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT174TABLE 164ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)175TABLE 165ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)175TABLE 166ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)175TABLE 167ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)176TABLE 168ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)176TABLE 169ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)177TABLE 170ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)177TABLE 171ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)177TABLE 172ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)178TABLE 173ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)178TABLE 174ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)17811.4.1JAPAN17911.4.1.1Rising geriatric population and growing focus on personalized medicine to propel market growth in Japan179TABLE 175JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025179TABLE 176JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)180TABLE 177JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)180TABLE 178JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)180TABLE 179JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)181TABLE 180JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)181TABLE 181JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)182TABLE 182JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)182TABLE 183JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)182TABLE 184JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)183TABLE 185JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)18311.4.2CHINA18311.4.2.1Growing stem cell research and the high incidence of chronic diseases to drive market growth in China183TABLE 186CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)184TABLE 187CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)184TABLE 188CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)185TABLE 189CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)185TABLE 190CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)185TABLE 191CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)186TABLE 192CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)186TABLE 193CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)186TABLE 194CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)187TABLE 195CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)18711.4.3INDIA18711.4.3.1Increasing government support for stem cell-based therapies and expansion of the pharmaceutical and biotechnology industries in India to support market growth187TABLE 196INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)188TABLE 197INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)188TABLE 198INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)189TABLE 199INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)189TABLE 200INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)189TABLE 201INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)190TABLE 202INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)190TABLE 203INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)190TABLE 204INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)191TABLE 205INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)19111.4.4REST OF ASIA PACIFIC191TABLE 206ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)192TABLE 207ROAPAC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)193TABLE 208ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)193TABLE 209ROAPAC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)194TABLE 210ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)194TABLE 211ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)195TABLE 212ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)195TABLE 213ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)195TABLE 214ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)196TABLE 215ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)19611.5LATIN AMERICA19611.5.1EXPANSION OF THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET GROWTH IN LATAM196TABLE 216LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)197TABLE 217LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)197TABLE 218LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)197TABLE 219LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)198TABLE 220LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)198TABLE 221LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)199TABLE 222LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)199TABLE 223LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)199TABLE 224LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)200TABLE 225LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)20011.6MIDDLE EAST & AFRICA20011.6.1RISING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST & AFRICA200TABLE 226MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)201TABLE 227MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)201TABLE 228MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)202TABLE 229MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)202TABLE 230MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)203TABLE 231MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)203TABLE 232MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)203TABLE 233MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)204TABLE 234MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)204TABLE 235MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)20412COMPETITIVE LANDSCAPE20512.1INTRODUCTION20512.2RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS206FIGURE 36SINGLE-CELL ANALYSIS MARKET: STRATEGIES ADOPTED20612.3REVENUE ANALYSIS207FIGURE 37REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS20712.4MARKET SHARE ANALYSIS207FIGURE 38SINGLE-CELL ANALYSIS MARKET SHARE, BY KEY PLAYER (2020)20812.5COMPANY EVALUATION QUADRANT20912.5.1STARS20912.5.2EMERGING LEADERS20912.5.3PERVASIVE PLAYERS20912.5.4PARTICIPANTS209FIGURE 39SINGLE-CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 201921012.6COMPANY EVALUATION QUADRANT: START-UPS/SMES21112.6.1PROGRESSIVE COMPANIES21112.6.2STARTING BLOCKS21112.6.3RESPONSIVE COMPANIES21112.6.4DYNAMIC COMPANIES211FIGURE 40SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 202021212.7COMPETITIVE BENCHMARKING21312.7.1COMPANY FOOTPRINT (20 COMPANIES)213FIGURE 41FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET21312.7.2COMPANY PRODUCT FOOTPRINT (20 COMPANIES)214TABLE 236PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET21412.7.3COMPANY REGIONAL FOOTPRINT (20 COMPANIES)215TABLE 237REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET21512.8COMPETITIVE SCENARIO AND TRENDS21612.8.1PRODUCT LAUNCHES216TABLE 238SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2018–JULY 202121612.8.2DEALS217TABLE 239SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2018–JULY 202121712.8.3OTHER DEVELOPMENTS218TABLE 240SINGLE-CELL ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2018–JULY 202121813COMPANY PROFILES219(Business overview, Products offered, Recent developments & MnM View)*13.1KEY COMPANIES21913.1.1BECTON, DICKINSON AND COMPANY219TABLE 241BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW219FIGURE 42BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)22013.1.2DANAHER CORPORATION224TABLE 242DANAHER CORPORATION: BUSINESS OVERVIEW224FIGURE 43DANAHER CORPORATION: COMPANY SNAPSHOT (2020)22413.1.3MERCK KGAA229TABLE 243MERCK KGAA: BUSINESS OVERVIEW229FIGURE 44MERCK KGAA: COMPANY SNAPSHOT (2020)23013.1.4THERMO FISHER SCIENTIFIC, INC.234TABLE 244THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW234FIGURE 45THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)23513.1.5QIAGEN N.V.239TABLE 245QIAGEN N.V.: BUSINESS OVERVIEW239FIGURE 46QIAGEN N.V.: COMPANY SNAPSHOT (2020)24013.1.610X GENOMICS242TABLE 24610X GENOMICS: BUSINESS OVERVIEW242FIGURE 4710X GENOMICS: COMPANY SNAPSHOT (2020)24213.1.7PROMEGA CORPORATION245TABLE 247PROMEGA CORPORATION: BUSINESS OVERVIEW24513.1.8ILLUMINA248TABLE 248ILLUMINA: BUSINESS OVERVIEW248FIGURE 48ILLUMINA: COMPANY SNAPSHOT (2020)24913.1.9BIO-RAD LABORATORIES252TABLE 249BIO-RAD LABORATORIES: BUSINESS OVERVIEW252FIGURE 49BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)25313.1.10FLUIDIGM CORPORATION257TABLE 250FLUIDIGM CORPORATION: BUSINESS OVERVIEW257FIGURE 50FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2020)25813.1.11AGILENT TECHNOLOGIES, INC.262TABLE 251AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW262FIGURE 51AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)26213.1.12CORNING INCORPORATED266TABLE 252CORNING INCORPORATED: BUSINESS OVERVIEW266FIGURE 52CORNING INCORPORATED: COMPANY SNAPSHOT (2020)26713.1.13TAKARA BIO INC.269TABLE 253TAKARA BIO INC.: BUSINESS OVERVIEW269FIGURE 53TAKARA BIO INC.: COMPANY SNAPSHOT (2020)26913.1.14BIOMÉRIEUX SA272TABLE 254BIOMÉRIEUX SA.: BUSINESS OVERVIEW272FIGURE 54BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)27213.1.15TECAN GROUP LTD.274TABLE 255TECAN GROUP LTD.: BUSINESS OVERVIEW274FIGURE 55TECAN GROUP LTD.: COMPANY SNAPSHOT (2020)27513.1.16SARTORIUS AG277TABLE 256SARTORIUS AG.: BUSINESS OVERVIEW277FIGURE 56SARTORIUS AG: COMPANY SNAPSHOT (2020)27813.1.17LUMINEX CORPORATION280TABLE 257LUMINEX CORPORATION: BUSINESS OVERVIEW280FIGURE 57LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)280*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.13.2OTHER PLAYERS28213.2.1OXFORD NANOPORE TECHNOLOGIES28213.2.2CYTEK BIOSCIENCES28313.2.3FLUXION BIOSCIENCES28413.2.4MENARINI SILICON BIOSYSTEMS28513.2.5APOGEE FLOW SYSTEMS LTD.28613.2.6NANOCELLECT BIOMEDICAL28713.2.7ON-CHIP BIOTECHNOLOGIES CO., LTD.28813.2.8RARECYTE, INC.28914APPENDIX29014.1DISCUSSION GUIDE29014.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL29314.3AVAILABLE CUSTOMIZATIONS29514.4RELATED REPORTS29514.5AUTHOR DETAILS296


お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com